RaySearch Laboratories to Showcase Meeting Innovations in Oncology

RaySearch Laboratories to Showcase Innovations at ASTRO 2025
RaySearch Laboratories AB (publ) is excited to announce its upcoming participation at the prestigious ASTRO 2025 event, where they will unveil cutting-edge innovations designed to transform the landscape of oncology care. Under the campaign titled "Coding Energy to End Cancer," RaySearch will demonstrate its advanced treatment planning system, RayStation, and its oncology information system, RayCare, contributing to a new standard in cancer treatment.
Key Focus Areas at ASTRO 2025
During ASTRO 2025, RaySearch will highlight five crucial focus areas that are set to shape the future of cancer care:
- Adaptive Radiotherapy: This innovative approach allows clinicians to tailor treatments continuously, adapting to each patient's needs throughout their therapy journey.
- Automated Workflows: By streamlining complex processes, RaySearch enhances both efficiency and quality of care, allowing healthcare professionals to focus more on patients.
- Integrated Planning: The seamless connection of systems and data leads to a more efficient treatment planning process, minimizing disruptions and errors.
- Analyzing Clinical Data: By transforming fragmented clinical information into actionable insights, RaySearch enables healthcare providers to make informed decisions quickly.
- Uniting the Industry: Collaborating with industry leaders such as IBA, Vision RT, GE Healthcare, C-RAD, and Leo Cancer Care, RaySearch promotes open and vendor-agnostic collaboration, which is essential for expanding innovation and choices in cancer care.
Exclusive Highlights at the RaySearch Booth
The exhibit will showcase the latest capabilities of RayStation, featuring groundbreaking technologies such as high-speed adaptive replanning and advanced AI-driven image segmentation. One of the notable highlights is the introduction of ECHO, an automated planning algorithm developed in collaboration with renowned institutions. The new Plan Explorer module also offers users a centralized interface to explore and compare diverse treatment options.
Revolutionizing Oncology Workflows with RayCare
RayCare's transformative approach will be demonstrated at the event, illustrating how it connects and streamlines every aspect of the cancer treatment process. With features like active oncology workflows and tight integration with treatment machines, RayCare elevates standards of efficiency and coordination.
Harnessing Data Insights through RayIntelligence
Another innovative product, RayIntelligence, is a cloud-based analytics system that aggregates data from multiple sources, providing clinicians with clear and actionable insights. Attendees are invited to engage with data dashboards to gain a comprehensive understanding of clinical operations.
µ-RayStation: Advancements in Research
RaySearch will also showcase µ-RayStation, a platform aimed at supporting small animal irradiation research, highlighting the company's dedication to advancing scientific knowledge in the field.
Johan Löf, the CEO of RaySearch, emphasizes the vision of a future where intelligent and unified systems reshape cancer care, empowering clinicians to deliver personalized, effective treatment in impactful ways.
About RaySearch Laboratories
RaySearch Laboratories AB (publ) is a leading medical technology company that develops innovative software solutions to enhance cancer treatment. Their product range includes RayStation® for treatment planning, RayCare® for oncology information systems, and the recently launched RayIntelligence® for data analytics, which collectively support over 1,100 clinics in 47 countries worldwide. Established in 2000, RaySearch continues its commitment to cancer care advancement, with its shares listed on Nasdaq Stockholm.
Frequently Asked Questions
What is RaySearch Laboratories focused on during ASTRO 2025?
RaySearch Laboratories aims to present its cutting-edge innovations in oncology, including RayStation and RayCare, under the theme of transforming cancer care.
What are some highlighted technologies at the event?
Key highlights include adaptive radiotherapy, automated workflows, integrated planning, and data analysis to enhance patient care and treatment personalization.
How does RayCare contribute to cancer treatment?
RayCare orchestrates and connects every step of the cancer treatment process, improving efficiency, coordination, and patient-centered care.
What is unique about RayIntelligence?
RayIntelligence is a cloud-based system that integrates fragmented data, providing clear insights and analytics to support clinical decisions.
Where can attendees learn more about RaySearch's innovations?
Attendees can see demonstrations and learn more about RaySearch's offerings at booth #2025 during ASTRO 2025.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.